The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
Open accessAbstract
A single high dose of interferon-β (IFNβ) activates powerful cellular responses, in which many anti-viral, pro-apoptotic, and anti-proliferative proteins are highly expressed. Since some of these proteins are deleterious, cells downregulate this initial response rapidly. However, the expression of many anti-viral proteins that do no harm is sustained, prolonging a substantial part of the initial anti-viral response for days and also providing resistance to DNA damage. While the transcription factor ISGF3 (IRF9 and tyrosine-phosphorylated STATs 1 and 2) drives the first rapid response phase, the related factor un-phosphorylated ISGF3 (U-ISGF3), formed by IFNβ-induced high levels of IRF9 and STATs 1 and 2 without tyrosine phosphorylation, drives the second prolonged response. The U-ISGF3-induced anti-viral genes that show prolonged expression are driven by distinct IFN stimulated response elements (ISREs). Continuous exposure of cells to a low level of IFNβ, often seen in cancers, leads to steady-state increased expression of only the U-ISGF3-dependent proteins, with no sustained increase in other IFNβ-induced proteins, and to constitutive resistance to DNA damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
WebLogo: A Sequence Logo Generator: Figure 1
Crooks, G. E., Hon, G., Chandonia, J.-M., & Brenner, S. E. (2004) · Genome Research · doi:10.1101/gr.849004 · Cited by 12,386
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Self-citationParadoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Interferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
Brass, A. L., Huang, I.-C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.017 · Cited by 1,269
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154
Self-citationImpaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency
Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I. Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., et al. (2003) · Nature Genetics · doi:10.1038/ng1097 · Cited by 816
Weichselbaum, R. R., Ishwaran, H., Yoon, T., Nuyten, D. S. A., Baker, S. W., Khodarev, N., Su, A. W., Shaikh, A. Y., Roach, P., Kreike, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809242105 · Cited by 615
Cárdenas, W. B., Loo, Y.-M., Gale, M., Hartman, A. L., Kimberlin, C. R., Martínez-Sobrido, L., Saphire, E. O., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02199-05 · Cited by 453
Detection of functional DNA motifs via statistical over-representation
Frith, M. C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh299 · Cited by 424
Multiple Functions of the IKK-Related Kinase IKKε in Interferon-Mediated Antiviral Immunity
tenOever, B. R., Ng, S.-L., Chua, M. A., McWhirter, S. M., García-Sastre, A., & Maniatis, T. (2007) · Science · doi:10.1126/science.1136567 · Cited by 342
Thijs, G., Marchal, K., Lescot, M., Rombauts, S., De Moor, B., Rouzé, P., & Moreau, Y. (2002) · Journal of Computational Biology · doi:10.1089/10665270252935566 · Cited by 342
Khodarev, N. N., Beckett, M., Labay, E., Darga, T., Roizman, B., & Weichselbaum, R. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308102100 · Cited by 326
Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes
Cheon, H., & Stark, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903487106 · Cited by 305
Self-citationMiyashita, M., Oshiumi, H., Matsumoto, M., & Seya, T. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01368-10 · Cited by 303
Interferon-γ links ultraviolet radiation to melanomagenesis in mice
Zaidi, M. R., Davis, S., Noonan, F. P., Graff-Cherry, C., Hawley, T. S., Walker, R. L., Feigenbaum, L., Fuchs, E., Lyakh, L., Young, H. A., et al. (2011) · Nature · doi:10.1038/nature09666 · Cited by 293 · cited 2×
“Activation of the JAK2/STAT1 pathway, not necessarily through phosphorylated STAT1, is related to myeloproliferative neoplasms (Chen et al , 2010), and blockade of IFN g reduced melano-magenesis (Zaidi et al , 2011).”
Lin, R.-J., Chang, B.-L., Yu, H.-P., Liao, C.-L., & Lin, Y.-L. (2006) · Journal of Virology · doi:10.1128/jvi.02714-05 · Cited by 286
STAT1 as a key modulator of cell death
Kim, H. S., & Lee, M.-S. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.09.003 · Cited by 279
Leonova, K. I., Brodsky, L., Lipchick, B., Pal, M., Novototskaya, L., Chenchik, A. A., Sen, G. C., Komarova, E. A., & Gudkov, A. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216922110 · Cited by 261
Schlender, J., Hornung, V., Finke, S., Günthner-Biller, M., Marozin, S., Brzózka, K., Moghim, S., Endres, S., Hartmann, G., & Conzelmann, K.-K. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5507-5515.2005 · Cited by 232
Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A
Duong, F. H. T., Filipowicz, M., Tripodi, M., La Monica, N., & Heim, M. H. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.076 · Cited by 222
Khodarev, N. N., Roizman, B., & Weichselbaum, R. R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3225 · Cited by 203
Herpes Simplex Virus 1 Has Multiple Mechanisms for Blocking Virus-Induced Interferon Production
Melroe, G. T., DeLuca, N. A., & Knipe, D. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8411-8420.2004 · Cited by 197
Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 Signaling
Chen, E., Beer, P. A., Godfrey, A. L., Ortmann, C. A., Li, J., Costa-Pereira, A. P., Ingle, C. E., Dermitzakis, E. T., Campbell, P. J., & Green, A. R. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.013 · Cited by 173
Khodarev, N. N., Minn, A. J., Efimova, E. V., Darga, T. E., Labay, E., Beckett, M., Mauceri, H. J., Roizman, B., & Weichselbaum, R. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1019 · Cited by 161
Itsui, Y., Sakamoto, N., Kakinuma, S., Nakagawa, M., Sekine‐Osajima, Y., Tasaka‐Fujita, M., Nishimura‐Sakurai, Y., Suda, G., Karakama, Y., Mishima, K., et al. (2009) · Hepatology · doi:10.1002/hep.23195 · Cited by 159
Herc5 Attenuates Influenza A Virus by Catalyzing ISGylation of Viral NS1 Protein
Tang, Y., Zhong, G., Zhu, L., Liu, X., Shan, Y., Feng, H., Bu, Z., Chen, H., & Wang, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903588 · Cited by 158
Cheon, H., Yang, J. B., & Stark, G. R. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0100 · Cited by 153
Self-citationRoberts, D., Schick, J. S., Conway, S. R., Biade, S., Laub, P. B., Stevenson, J. P., Hamilton, T. C., O'Dwyer, P. J., & Johnson, S. W. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602447 · Cited by 142
Phospholipid Scramblase 1 Potentiates the Antiviral Activity of Interferon
Dong, B., Zhou, Q., Zhao, J., Zhou, A., Harty, R. N., Bose, S., Banerjee, A. K., Slee, R. B., Guenther-Johnson, J. M., Williams, B. R. G., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.8983-8993.2004 · Cited by 135
Duarte, C. W., Willey, C. D., Zhi, D., Cui, X., Harris, J. J., Vaughan, L. K., Mehta, T. S., McCubrey, R. O., Khodarev, N. N., Weichselbaum, R. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029653 · Cited by 133
Martinez-Moczygemba, M., Gutch, M. J., French, D. L., & Reich, N. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20070 · Cited by 132
STAT1 Pathway Mediates Amplification of Metastatic Potential and Resistance to Therapy
Khodarev, N. N., Roach, P., Pitroda, S. P., Golden, D. W., Bhayani, M. K., Shao, M. Y., Darga, T. E., Beveridge, M. G., Sood, R. F., Sutton, H. G., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005821 · Cited by 122
Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis
Cai, D., Cao, J., Li, Z., Zheng, X., Yao, Y., Li, W., & Yuan, Z. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-102 · Cited by 118
Suomela, S., Cao, L. H., Bowcock, A. M., & Saarialho‐Kere, U. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22322.x · Cited by 110
HERC6 Is the Main E3 Ligase for Global ISG15 Conjugation in Mouse Cells
Oudshoorn, D., van Boheemen, S., Sánchez-Aparicio, M. T., Rajsbaum, R., García‐Sastre, A., & Versteeg, G. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029870 · Cited by 107
Stochastic Receptor Expression Determines Cell Fate upon Interferon Treatment
Levin, D., Harari, D., & Schreiber, G. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05251-11 · Cited by 105
Hatano, H., Kudo, Y., Ogawa, I., Tsunematsu, T., Kikuchi, A., Abiko, Y., & Takata, T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4761 · Cited by 101
Łuszczek, W., Cheriyath, V., Mekhail, T. M., & Borden, E. C. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0309 · Cited by 87
The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: Friend or foe?☆
Andersen, J. B., & HASSEL, B. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.10.001 · Cited by 82
Rickardson, L., Fryknäs, M., Dhar, S., Lövborg, H., Gullbo, J., Rydåker, M., Nygren, P., Gustafsson, M. G., Larsson, R., & Isaksson, A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602699 · Cited by 82
Schmeisser, H., Mejido, J., Balinsky, C. A., Morrow, A., Clark, C. R., Zhao, T., & Zoon, K. C. (2010) · Journal of Virology · doi:10.1128/jvi.00818-10 · Cited by 81
Tan, J., Qiao, W., Wang, J., Xu, F., Li, Y., Zhou, J., Chen, Q., & Geng, Y. (2008) · Journal of Virology · doi:10.1128/jvi.02249-07 · Cited by 79
Perwitasari, O., Cho, H., Diamond, M., & Gale, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.285205 · Cited by 74
Morrow, A., Schmeisser, H., Tsuno, T., & Zoon, K. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001359 · Cited by 74
Gongora, C., Candeil, L., Vezzio, N., Copois, V., Denis, V., Bareil, C., Molina, F., Fraslon, C., Fraslon, C., Conseiller, E., et al. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.6.5838 · Cited by 40
Cited by
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3581 · Cited by 3,297
ISG15 in antiviral immunity and beyond
Perng, Y.-C., & Lenschow, D. J. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0020-5 · Cited by 855
The JAK-STAT pathway at 30: Much learned, much more to do
Philips, R. L., Wang, Y., Cheon, H., Kanno, Y., Gadina, M., Sartorelli, V., Horvath, C. M., Darnell, J. E., Stark, G. R., & O’Shea, J. J. (2022) · Cell · doi:10.1016/j.cell.2022.09.023 · Cited by 720
Self-citationDecoding type I and III interferon signalling during viral infection
Mesev, E. V., LeDesma, R. A., & Ploss, A. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0421-x · Cited by 538
Interferons and viruses: an evolutionary arms race of molecular interactions
Hoffmann, H.-H., Schneider, W. M., & Rice, C. M. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.01.004 · Cited by 410
Self-citation
Metadata
- Authors
- Cheon, H., Holvey-Bates, E. G., Schoggins, J. W., Forster, S., Hertzog, P., Imanaka, N., Rice, C. M., Jackson, M. W., Junk, D. J., & Stark, G. R.
- Venue
- The EMBO Journal
- Published
- 2013-09-24
- Volume
- 32
- Issue
- 20
- Pages
- 2751-2763
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2113174452
- Cited by
- 334
- References
- 50
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.